Lin, C.-C., Garralda, E., Schöffski, P., Hong, D. S., Siu, L. L., Martin, M., Maur, M., Hui, R., Soo, R. A., Chiu, J., Zhang, T., Ma, B., Kyi, C., Tan, D. S., Cassier, P. A., Sarantopoulos, J., Weickhardt, A., Carvajal, R. D., Spratlin, J., … De Braud, F. (2023). A phase 2, multicenter, open-label study of anti-LAG-3 ieramilimab in combination with anti-PD-1 spartalizumab in patients with advanced solid malignancies. OncoImmunology, 13(1). https://doi.org/10.1080/2162402x.2023.2290787

Cytryn, S. L., Moy, R. H., Cowzer, D., Shah, R. H., Chou, J. F., Joshi, S. S., Ku, G. Y., Maron, S. B., Desai, A., Yang, J., Sugarman, R., Rao, D., Goldberg, Z., Charalambous, C., Lapshina, M., Antoine, A., Socolow, F., Trivedi, N., Capanu, M., … Janjigian, Y. Y. (2023). First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: a single-arm, single-centre, phase 2 trial. The Lancet Oncology, 24(10), 1073–1082. https://doi.org/10.1016/s1470-2045(23)00358-3

Sato, T., Matsumura, M., Yamamoto, K., Shlofmitz, E., Moses, J. W., Khalique, O. K., Thomas, S. V., Tsoulios, A., Cohen, D. J., Mintz, G. S., Shlofmitz, R. A., Jeremias, A., Ali, Z. A., & Maehara, A. (2023). Impact of Eruptive vs Noneruptive Calcified Nodule Morphology on Acute and Long-Term Outcomes After Stenting. JACC: Cardiovascular Interventions, 16(9), 1024–1035. https://doi.org/10.1016/j.jcin.2023.03.009

Yeboah-Korang, A., Memon, A., Patel, N., Portocarrero-Castillo, A., Osman, A., Kleesattel, D., Lopez, C., Louissaint, J., Sherman, K., & Fontana, R. (2022). Impact of Prior Drug Allergies on the Risk, Clinical Features, and Outcomes of Idiosyncratic Drug-Induced Liver Injury in Adults. Digestive Diseases and Sciences, 67(11), 5262–5271. https://doi.org/10.1007/s10620-022-07403-0

Mishra, N., Ng, J., Strom, M. A., Jain, K., Thakkar, R., Joshi, S., Pereira, M., Shah, L., Grossman, M. E., Lee, M. J., De Michele, S., Silvers, D. N., Faust, P. L., Lipkin, W. I., & Gallitano, S. M. (2022). Human Polyomavirus 9—An Emerging Cutaneous and Pulmonary Pathogen in Solid Organ Transplant Recipients. JAMA Dermatology, 158(3), 293. https://doi.org/10.1001/jamadermatol.2021.5853